Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Ross

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
European Urology|November 6, 2016
Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate TumorsEmilie Lalonde, Rached Alkallas, Melvin Lee Kiang Chua, et al.
Oncotarget|October 13, 2016
HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancerHelen Ross-Adams, Stephen Ball, Kate Lawrenson, et al.
Plos One|October 23, 2010
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urineHayley C Whitaker, Zsofia Kote-Jarai, Helen Ross-Adams, et al.
Oncotarget|February 17, 2016
A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese populationJacek Marzec, Xueying Mao, Meiling Li, et al.
The Lancet. Oncology|December 3, 2014
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort studyEmilie Lalonde, Adrian S Ishkanian, Jenna Sykes, et al.
Human Molecular Genetics|March 29, 2013
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expressionZsofia Kote-Jarai, Edward J Saunders, Daniel A Leongamornlert, et al.
Nature Genetics|February 7, 2012
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke, , Céline Bellenguez, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
European Urology|November 6, 2016
Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate TumorsEmilie Lalonde, Rached Alkallas, Melvin Lee Kiang Chua, et al.
Oncotarget|October 13, 2016
HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancerHelen Ross-Adams, Stephen Ball, Kate Lawrenson, et al.
Plos One|October 23, 2010
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urineHayley C Whitaker, Zsofia Kote-Jarai, Helen Ross-Adams, et al.
Oncotarget|February 17, 2016
A genetic study and meta-analysis of the genetic predisposition of prostate cancer in a Chinese populationJacek Marzec, Xueying Mao, Meiling Li, et al.
The Lancet. Oncology|December 3, 2014
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort studyEmilie Lalonde, Adrian S Ishkanian, Jenna Sykes, et al.
Human Molecular Genetics|March 29, 2013
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expressionZsofia Kote-Jarai, Edward J Saunders, Daniel A Leongamornlert, et al.
Nature Genetics|February 7, 2012
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke, , Céline Bellenguez, et al.
Pageof 5